Korean heart failure drug under Real-World watch
NCT ID NCT06148935
Summary
This study monitors the safety of vericiguat, an approved heart failure medication, in routine Korean medical practice. Researchers will track 1,350 patients with chronic heart failure for up to 12 months to identify any side effects and see how well the drug works in real-world settings. The study collects data from medical records rather than testing new treatments, focusing on safety monitoring after the drug's approval.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many Locations
RECRUITINGMultiple Locations, South Korea
Conditions
Explore the condition pages connected to this study.